Both in Pharmaceuticals
Enliven Therapeutics vs Dyne Therapeutics
Over the past year ELVN returned +148.6% and DYN returned −13.8%; their daily moves had a correlation of 0.24.
ELVN +148.6% DYN −13.8%Growth of $1, one year, split-adjusted
| Metric | ELVN | DYN |
|---|---|---|
| Price | $47.25 | $18.54 |
| Market cap | $3.46B | $3.46B |
| Today | +5.40% | +2.71% |
| 1 month | +11.5% | +20.4% |
| 6 months | +14.7% | −1.6% |
| Year to date | +206.8% | −5.2% |
| 1 year | +136.3% | −23.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $895.2M | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 59.8% |
| Short % of float | 16.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).